California will soon become the first state to offer its own affordable insulin, with Gov. Gavin Newsom announcing that CalRx biosimilar insulin ...

California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell an affordable version of the drug to residents, Gov. Gavin Newsom announced ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

TREVOSE, Pa., Nov. 7, 2022 /PRNewswire/ -- Lannett Company, Inc. (LCI) today announced that it has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the pen injector device ...

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s ...

California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell ...